Search research articles
Contact Us
Filters
Showing results (1-10 of 260) with videos related to
Page
of 26
Sort By:
The Lancet. HIV
|
October 6, 2023
HIV-related CNS infections: translating DREAMM into reality
David B Meya, Graeme Meintjes
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 17, 2020
Reply to the Author
Edward Mpoza, David B Meya
Therapeutics
|
June 17, 2026
HIV-Associated Cryptococcal Meningitis: A Call for Action for New Treatment Options
Samuel Okurut, David B Meya
The New England Journal of Medicine
|
September 18, 2014
Antiretroviral therapy after cryptococcal meningitis
David R Boulware, David B Meya
The New England Journal of Medicine
|
May 1, 2024
Cryptococcal Disease in Diverse Hosts
David B Meya, Peter R Williamson
The New England Journal of Medicine
|
January 24, 2024
Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults
Jayne Ellis, David B Meya, Fiona C Cresswell
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 14, 2012
Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care
Radha Rajasingham, David B Meya, David R Boulware
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 14, 2013
Accuracy of pima point-of-care CD4 analyzer in routine use in public health clinics in Uganda
Bozena M Morawski, David B Meya, David R Boulware
Medical Mycology Case Reports
|
June 7, 2023
Persistently elevated intracranial pressure in cryptococcal meningitis- 76 therapeutic lumbar punctures
Samuel Jjunju, Edwin Nuwagira, David B Meya, et al.
The Lancet. Infectious Diseases
|
September 28, 2016
Sertraline for HIV-associated cryptococcal meningitis - Authors' reply
Joshua Rhein, Kirsten Nielsen, David R Boulware, et al.
Page
of 26
Search research articles
Search
Showing results (1-10 of 260) with videos related to
Sort By:
Page
of 26
The Lancet. HIV
|
October 6, 2023
HIV-related CNS infections: translating DREAMM into reality
David B Meya, Graeme Meintjes
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 17, 2020
Reply to the Author
Edward Mpoza, David B Meya
Therapeutics
|
June 17, 2026
HIV-Associated Cryptococcal Meningitis: A Call for Action for New Treatment Options
Samuel Okurut, David B Meya
The New England Journal of Medicine
|
September 18, 2014
Antiretroviral therapy after cryptococcal meningitis
David R Boulware, David B Meya
The New England Journal of Medicine
|
May 1, 2024
Cryptococcal Disease in Diverse Hosts
David B Meya, Peter R Williamson
The New England Journal of Medicine
|
January 24, 2024
Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults
Jayne Ellis, David B Meya, Fiona C Cresswell
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 14, 2012
Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care
Radha Rajasingham, David B Meya, David R Boulware
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 14, 2013
Accuracy of pima point-of-care CD4 analyzer in routine use in public health clinics in Uganda
Bozena M Morawski, David B Meya, David R Boulware
Medical Mycology Case Reports
|
June 7, 2023
Persistently elevated intracranial pressure in cryptococcal meningitis- 76 therapeutic lumbar punctures
Samuel Jjunju, Edwin Nuwagira, David B Meya, et al.
The Lancet. Infectious Diseases
|
September 28, 2016
Sertraline for HIV-associated cryptococcal meningitis - Authors' reply
Joshua Rhein, Kirsten Nielsen, David R Boulware, et al.
Page
of 26